Drug Safety Alerts from New Zealand Health Authority

Drug Safety Alerts from New Zealand Health Authority-MedSafe

MedSafe- Health Authority of New Zealand government has released the below drug safety information in their latest issue-June-2020 to update public-(health care professionals & consumers) about the safe use of medicines.   Tramadol use Contradicted in children & elder patients (<75 y) Oral cleft defects associated with ondansetron   Tramadol use Contradicted in children &

Hyperacusis associated with Tramadol: A Drug Safety Signal

Hyperacusis is new drug safety signal identified for Tramadol drug by UMC (Uppsala Monitoring Center), a WHO Collaborating Centre. Hyperacusis is a rare hearing disorder which is characterized by an increased sensitivity to certain frequencies and volume ranges of sound. This disorder makes it hard to deal with everyday sounds and causes an intolerance to

error: Content is protected !!